IRIS
BUCCISANO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.185
EU - Europa 1.759
AS - Asia 457
AF - Africa 69
SA - Sud America 54
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.545
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.143
DE - Germania 966
IT - Italia 320
CN - Cina 179
FR - Francia 136
GB - Regno Unito 101
IN - India 88
NL - Olanda 33
ID - Indonesia 31
VN - Vietnam 30
SE - Svezia 29
EG - Egitto 28
IE - Irlanda 26
CA - Canada 24
ZA - Sudafrica 24
RU - Federazione Russa 22
BR - Brasile 20
JP - Giappone 19
AE - Emirati Arabi Uniti 16
CZ - Repubblica Ceca 15
MX - Messico 15
AU - Australia 13
FI - Finlandia 12
PE - Perù 12
RO - Romania 12
GR - Grecia 11
KR - Corea 11
CL - Cile 10
DK - Danimarca 10
SG - Singapore 10
UA - Ucraina 10
PL - Polonia 9
HK - Hong Kong 8
MY - Malesia 8
PK - Pakistan 8
TR - Turchia 8
ES - Italia 7
NO - Norvegia 7
AR - Argentina 6
BE - Belgio 6
CH - Svizzera 6
IR - Iran 6
PT - Portogallo 6
SA - Arabia Saudita 6
IQ - Iraq 5
TH - Thailandia 5
CO - Colombia 4
PH - Filippine 4
TW - Taiwan 4
AP - ???statistics.table.value.countryCode.AP??? 3
AT - Austria 3
DZ - Algeria 3
ET - Etiopia 3
KE - Kenya 3
AL - Albania 2
BY - Bielorussia 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
MK - Macedonia 2
PG - Papua Nuova Guinea 2
PY - Paraguay 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LY - Libia 1
ML - Mali 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
SD - Sudan 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
YE - Yemen 1
ZW - Zimbabwe 1
Totale 4.545
Salva come PNG Salva come JPEG
Città #
Woodbridge 381
Houston 265
Fairfield 172
Ashburn 113
Santa Cruz 102
Seattle 99
Buffalo 94
Wilmington 94
Rome 87
Ann Arbor 85
Nürnberg 68
Cambridge 58
Guangzhou 34
University Park 31
Beijing 28
Shanghai 26
Dublin 24
Mountain View 24
Stockholm 24
Chicago 21
Milan 21
Dong Ket 20
Muizenberg 19
Boardman 17
San Diego 17
Hangzhou 16
Bengaluru 14
Leawood 13
Los Angeles 13
Florence 12
Delhi 11
Henderson 11
Phoenix 11
Bologna 10
Chennai 10
Columbus 10
Helsinki 10
Jakarta 10
Amsterdam 9
Lima 9
Ottawa 9
Cedar Knolls 8
Las Vegas 8
Wuhan 8
Atlanta 7
Duncan 7
Hudsonville 7
Paris 7
Perugia 7
Riva 7
Cairo 6
Chengdu 6
Council Bluffs 6
Dallas 6
Lake Forest 6
Middletown 6
New York 6
San Francisco 6
Zhengzhou 6
Birmingham 5
Hanoi 5
Madison 5
Mexico 5
Montemarciano 5
Naples 5
Padova 5
Provo 5
Scranton 5
Tokyo 5
Turin 5
Zurich 5
Batu Pahat 4
Cernusco sul Naviglio 4
Frankfurt am Main 4
Fremont 4
Kuala Lumpur 4
London 4
Messina 4
Palermo 4
Saint-Julien-en-Genevois 4
San Jose 4
Shenzhen 4
Tarnowskie Gory 4
Tianjin 4
Viricelles 4
Arvada 3
Bari 3
Beverly 3
Boston 3
Brooklyn 3
Brussels 3
Catania 3
Clearwater 3
Denver 3
Farmington 3
Gurgaon 3
Hartford 3
Issy-les-Moulineaux 3
Jacksonville 3
Jersey City 3
Totale 2.383
Salva come PNG Salva come JPEG
Nome #
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia, file e291c0d4-3ea6-cddb-e053-3a05fe0aa144 927
Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management., file e291c0d4-3eab-cddb-e053-3a05fe0aa144 570
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias, file e291c0d3-f756-cddb-e053-3a05fe0aa144 458
The revised IPSS predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WPSS: validation by the GROM Italian regional database, file e291c0d4-7e0b-cddb-e053-3a05fe0aa144 403
Treatment of Acute Myeloid Leukemia with 20-30% Bone Marrow Blasts, file e291c0d4-7b99-cddb-e053-3a05fe0aa144 279
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party, file e291c0d9-ba2a-cddb-e053-3a05fe0aa144 270
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia, file e291c0d6-4003-cddb-e053-3a05fe0aa144 268
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications, file e291c0d6-47b5-cddb-e053-3a05fe0aa144 179
Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia, file e291c0d7-0fa1-cddb-e053-3a05fe0aa144 163
Minimal residual disease detection in pediatric acute myeloid leukemia: does flow cytometry score a point over molecular biology?, file e291c0d4-7e94-cddb-e053-3a05fe0aa144 153
Therapeutic Choice in Older Patients with Acute Myeloid Leukemia: A Matter of Fitness, file e291c0d7-9d10-cddb-e053-3a05fe0aa144 135
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE, file e291c0d7-90d4-cddb-e053-3a05fe0aa144 125
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting, file e291c0d8-1b26-cddb-e053-3a05fe0aa144 98
Fludarabine, Cytarabine and Gentuzumab Ozogamicin (FLA-GO) as Salvage Therapy and Bridge to Transplant in Adult Relapsed Acute Myeloid Leukemia (AML) Patients, file e291c0d8-1e39-cddb-e053-3a05fe0aa144 79
Phase III, randomized, placebo-controlled trial of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes, file e291c0d9-bbed-cddb-e053-3a05fe0aa144 72
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production, file 3c6f4b71-feb8-4e84-86fc-b8cef6fbdc07 69
Case report: A Saprochaete clavata (Magnusiomyces clavatus) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcoma, file 74f64071-7412-47ae-b806-4d24c769eda4 63
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation, file e291c0d9-2a77-cddb-e053-3a05fe0aa144 62
MRD in AML: The Role of New Techniques, file e291c0d8-a47c-cddb-e053-3a05fe0aa144 60
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations, file e291c0d9-7cc1-cddb-e053-3a05fe0aa144 58
Clinical relevance of an objective - limit of detection - limit of quantification - based flow cytometry approach for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial, file e291c0d9-7de8-cddb-e053-3a05fe0aa144 42
FEVER OF UNKNOWN ORIGIN AND MULTIDRUG-RESISTANT ORGANISMS COLONIZATION IN AML PATIENTS, file cac52580-51dc-4cc0-894a-49ae9c34e1ec 35
In BCR-ABL1 Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia, file e291c0d9-bf7a-cddb-e053-3a05fe0aa144 33
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment, file ba3f3bba-c1cd-4d5e-85a6-0daf4d622e1c 23
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients, file 50857deb-e47a-43e4-9c95-91c089143be4 12
Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia, file 64e70885-5e6c-4708-966b-648171860d4f 12
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience, file 12096872-3a59-49c9-a096-87c15eb49382 11
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience, file 47eac2e3-aee8-47a1-8934-17ed6f2c3fa8 10
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION, file f31a1352-296d-4e72-9c93-62aa4c212699 10
Pulmonary function testing for fitness assessment in asymptomatic adults with newly diagnosed acute myeloid leukemia, file f416e02f-ee96-488c-a79d-8ce02895329c 10
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide, file dee53335-1e29-4468-ac25-d6de6f925c8f 9
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML, file aabf8caf-ff87-4c0c-8774-ac96152f1a53 8
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications, file 4761eef2-f38e-4c2a-8b90-7b254c47a00c 7
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia, file 30b4320e-d753-4181-bf67-2061024c713b 6
Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy, file f04df6c4-0a1d-44f8-83bb-a312075b5069 6
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel, file dfcb8900-1d2b-405f-b7e2-ee565cfa9a1a 2
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia, file e291c0d6-cd8b-cddb-e053-3a05fe0aa144 2
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia, file e291c0d8-1b47-cddb-e053-3a05fe0aa144 2
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients, file f257a963-96c3-476f-b438-ff203517d771 2
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature, file e291c0d6-4000-cddb-e053-3a05fe0aa144 1
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia, file e291c0d8-d450-cddb-e053-3a05fe0aa144 1
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): Phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial, file e291c0d9-01ec-cddb-e053-3a05fe0aa144 1
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis, file e291c0d9-16e6-cddb-e053-3a05fe0aa144 1
Totale 4.737
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.958
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019227 0 0 0 0 0 0 0 0 0 62 82 83
2019/2020655 71 63 56 40 56 54 54 53 70 49 56 33
2020/2021605 49 72 38 52 59 39 57 42 47 54 46 50
2021/2022727 39 33 29 69 67 40 65 59 56 65 141 64
2022/2023696 27 48 116 98 46 70 62 43 41 44 62 39
2023/2024491 60 41 45 37 59 72 60 66 38 13 0 0
Totale 4.737